Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Past 7 days
    • Any time
    • Past hour
    • Past 24 hours
    • Past 30 days

News

The Lancet5d
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Copyright: © 2015 Elsevier Ltd. Published by Elsevier Ltd.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

On foreign steel tariffs
PBS sues Trump admin
On COVID vaccine for kids
Emmy-winning actress dies
Trump fires Kim Sajet
Zion Williamson sued
On Medicaid cuts
US inflation gauge cools
John Thrasher dies
Third suspect arrested
Vetoes rent algorithms ban
Buys back first six albums
Mondelez sues Aldi
On NY school mascot ban
SC mass shooting arrest
McCullers hires security
Sued over wrongful arrests?
Cuts clean energy projects
Brand pleads not guilty
US trade deficit narrows
Oval Office sendoff
Zelenskyy meets US senators
Placed on 15-day IL
‘Simpsons' composer dies
Trump accuses China
DOJ moves to dismiss case
Targets visa applicants
Nigeria floods
Sale reaches 2,500 strikeouts
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy